Mainka, Stefan http://orcid.org/0000-0002-6970-7333
Lauermann, Maximilian
Ebersbach, Georg http://orcid.org/0000-0003-3403-6987
Funding for this research was provided by:
Deutsche Parkinson Vereinigung
Article History
Received: 30 December 2022
Accepted: 6 March 2023
First Online: 14 March 2023
Change Date: 15 May 2023
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00702-023-02646-1
Declarations
:
: Stefan Mainka and Maximilian Lauermann have no conflict of interest to report. Georg Ebersbach received honoraria for advisory board or consultancy from AbbVie Pharma, BIAL Pharma, Biogen GmbH, Desitin Pharma, STADA Pharma, and Neuroderm Inc. He received speaker honoraria from AbbVie Pharma, BIAL Pharma, Britannia Pharma, Desitin Pharma, Licher GmbH, UCB Pharma, and Zambon Pharma. He received royalties from Kohlhammer Verlag and Thieme Verlag.